| View |
|
DR-XY45413
|
Salbutamol (As Sulfate) + Ipratropium Bromide
|
I-Breath Plus
|
100mcg/20mcg
|
Metered Dose Inhaler
|
-
|
The ACME Laboratories Ltd.
|
Bangladesh
|
Initial (Variation)
|
28 February 2023
|
28 February 2028
|
| View |
|
DR-XY45418
|
Omeprazole
|
Omzep-DR
|
20mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
23 June 2021
|
01 June 2026
|
| View |
|
DR-XY45420
|
Saccharomyces Boulardii
|
Esbold
|
282.5 mg (each Sachet contains 250 mg Saccharomyces bouldarii yeast, equivalent to 5 Billion
CFU)
|
Lyophilized Powder For Oral Suspension
|
Antidiarrheal
|
Sai Mirra Innopharm Pvt. Ltd.
|
India
|
Automatic Renewal
|
12 March 2021
|
15 June 2026
|
| View |
|
DR-XY45422
|
Ketoconazole
|
None
|
20mg/g (2% w/w)
|
Cream
|
Antifungal
|
M.C.B. Dermatological Products
|
Philippines
|
Automatic Renewal
|
07 June 2021
|
01 June 2026
|
| View |
|
DR-XY45423
|
Pregabalin
|
Rhyma
|
75 mg
|
Capsule
|
Antiepileptic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
09 June 2021
|
01 June 2026
|
| View |
|
DR-XY45425
|
D-Alpha -Tocopherol (Vitamin E)
|
Orovite-E
|
400 IU
|
Softgel Capsule
|
Vitamin
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
24 March 2021
|
06 June 2026
|
| View |
|
DR-XY45429
|
Paclitaxel
|
Clipax
|
6mg/mL (30mg/5mL)
|
Concentrate Solution For Injection (Iv)
|
-
|
Beijing SL Pharmaceutical Co., Ltd.
|
China
|
-
|
19 February 2021
|
03 June 2026
|
| View |
|
DR-XY45431
|
Betamethasone (As Valerate)
|
None
|
1mg per gram (0.1% w/w)
|
Topical Cream
|
-
|
M.C.B. Dermatological Products
|
Philippines
|
-
|
14 June 2021
|
06 June 2026
|
| View |
|
DR-XY45432
|
Foxin
|
Cefoxitin (As Sodium)
|
1 g
|
Powder for Solution for Injection (IM/IV)
|
-
|
Haikou Pharmaceutical Factory Co., Ltd.
|
China
|
-
|
14 May 2021
|
04 July 2026
|
| View |
|
DR-XY45433
|
Immuzinc
|
Zinc
|
10mg (equivalent to 27.5mg Zinc Sulfate Monohydrate)
|
Syrup (Oral Drops)
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
17 May 2021
|
09 June 2026
|
| View |
|
DR-XY45435
|
Ciprofloxacin (As Hydrochloride) + Fluocinolone Acetonide
|
Cetraxal Plus
|
3 mg/250 mcg per mL
|
Otic Solution (Ear Drops)
|
Otological (Corticosteroid and Anti-infective)
|
Laboratorios Salvat, S.A.
|
Spain
|
Initial [from Monitored-Release]
|
13 July 2022
|
11 October 2026
|
| View |
|
DR-XY45437
|
Metronidazole
|
Flagyzole
|
5 mg/mL (500 mg/100 mL)
|
Solution For Intravenous Infusion
|
Antiprotozoal (Imidazole derivative)
|
Friends Pharma (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
19 March 2021
|
10 June 2026
|
| View |
|
DR-XY45438
|
Ibuprofen
|
None
|
200 mg
|
Softgel Capsule
|
-
|
Phil Inter Pharma Co., Ltd.
|
Vietnam
|
Initial (Variation)
|
10 October 2022
|
10 October 2027
|
| View |
|
DR-XY45439
|
Ketamine (As Hydrochloride)
|
None
|
50 mg/mL
|
Solution For Injection
|
General Anesthetic
|
Myungmoon Pharmaceutical Co., Ltd.
|
Korea
|
Automatic Renewal
|
07 June 2023
|
08 June 2028
|
| View |
|
DR-XY45441
|
Tramadol Hydrochloride
|
Ramol
|
50 mg
|
Capsule
|
Opioid Analgesic
|
Macter International Ltd.
|
Pakistan
|
Automatic Renewal
|
24 June 2021
|
13 June 2026
|
| View |
|
DR-XY45442
|
Empagliflozin + Metformin Hydrochloride
|
Jardiance Duo
|
5mg/ 500mg
|
Film-Coated Tablet
|
Antidiabetic
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Initial (from Monitored Release status)
|
03 December 2021
|
16 June 2026
|
| View |
|
DR-XY45443
|
Empagliflozin + Metformin Hydrochloride
|
Jardiance Duo
|
5mg/ 850 mg
|
Film-Coated Tablet
|
Antidiabetic
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Initial (from Monitored Release status)
|
03 December 2021
|
16 June 2026
|
| View |
|
DR-XY45444
|
Empagliflozin + Metformin Hydrochloride
|
Jardiance Duo
|
5mg/1g
|
Film-Coated Tablet
|
-
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Initial (from Monitored Release)
|
07 December 2022
|
16 June 2027
|
| View |
|
DR-XY45445
|
Empagliflozin + Metformin Hydrochloride
|
Jardiance Duo
|
12.5mg/ 500mg
|
Film-Coated Tablet
|
-
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
-
|
03 December 2021
|
16 June 2026
|
| View |
|
DR-XY45446
|
Empagliflozin + Metformin Hydrochloride
|
Jardiance Duo
|
12.5mg/ 850mg
|
Film-Coated Tablet
|
Antidiabetic
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Initial (from Monitored Release status)
|
03 December 2021
|
16 June 2026
|